Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASADay One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in children.Continue reading
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug | 5 | 7 | 07-04-2026 |
| 2 | Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis | 0 | 5 | 08-04-2026 |
| 3 | Why Biogen Is Paying $5.6B to Buy Apellis Pharma | 0 | 5 | 03-04-2026 |
| 4 | eMed, Nitra Secure Hundreds of Millions in Funding | 0 | 5 | 06-04-2026 |
| 5 | New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer | 5 | 7 | 02-07-2026 |
| 6 | New targeted therapy shows promising early results in advanced pancreatic cancer | 2 | 7 | 05-07-2026 |
| 7 | New experimental approach may help overcome drug resistance in deadly brain cancer | 5 | 8 | 09-07-2026 |
| 8 | FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic TNBC | 5 | 7 | 24-06-2026 |
| 9 | GA-Renova & CCA in race to buy American oncology: Siemens Healthineers looking to exit non-core business for Rs 1,500 crore | 0 | 7 | 09-07-2026 |